BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23865788)

  • 1. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease.
    Matthews CA
    J Womens Health (Larchmt); 2013 Sep; 22(9):755-9. PubMed ID: 23865788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
    Matthews CA
    Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Clin Obstet Gynecol; 2007 Jun; 50(2):354-61. PubMed ID: 17513923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective oophorectomy for benign gynecological disorders.
    Shoupe D; Parker WH; Broder MS; Liu Z; Farquhar C; Berek JS
    Menopause; 2007; 14(3 Pt 2):580-5. PubMed ID: 17476148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
    Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
    Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
    Hickey M; Ambekar M; Hammond I
    Hum Reprod Update; 2010; 16(2):131-41. PubMed ID: 19793841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Obstet Gynecol; 2005 Aug; 106(2):219-26. PubMed ID: 16055568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
    Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
    Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profits of post-menopausal ovarian conservation at the time of hysterectomy for benign disease: mirage or reality?].
    Ouldamer L; Marret H; Jacquet A; Denakpo J; Body G
    J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):123-9. PubMed ID: 23201029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study.
    Jacoby VL; Grady D; Wactawski-Wende J; Manson JE; Allison MA; Kuppermann M; Sarto GE; Robbins J; Phillips L; Martin LW; O'Sullivan MJ; Jackson R; Rodabough RJ; Stefanick ML
    Arch Intern Med; 2011 Apr; 171(8):760-8. PubMed ID: 21518944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
    Plusquin C; Fastrez M; Vandromme J; Rozenberg S
    Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
    Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
    Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
    Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease.
    Parker WH
    Menopause; 2014 Feb; 21(2):192-4. PubMed ID: 23880797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oophorectomy: the debate between ovarian conservation and elective oophorectomy.
    Erekson EA; Martin DK; Ratner ES
    Menopause; 2013 Jan; 20(1):110-4. PubMed ID: 22929033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
    Parker WH; Broder MS; Chang E; Feskanich D; Farquhar C; Liu Z; Shoupe D; Berek JS; Hankinson S; Manson JE
    Obstet Gynecol; 2009 May; 113(5):1027-1037. PubMed ID: 19384117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
    Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
    Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.
    Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD
    Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian conservation vs removal at the time of benign hysterectomy.
    Adelman MR; Sharp HT
    Am J Obstet Gynecol; 2018 Mar; 218(3):269-279. PubMed ID: 28784419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.